InAADR

Drug Information

Drug Name: Bucindolol (71119-11-4)
PubChem ID: 51045
SMILES: CC(C)(CC1=CNC2=CC=CC=C21)NCC(COC3=CC=CC=C3C#N)O
InchiKey: FBMYKMYQHCBIGU-UHFFFAOYSA-N
Therapeutic Category: Adrenergic Agents, Adrenergic alpha-1 Receptor Antagonists, Adrenergic alpha-Antagonists, Adrenergic Antagonists, Adrenergic beta-Antagonists, Autonomic Agents, Cardiovascular Agents, Neurotransmitter Agents, Peripheral Nervous System Agents, Sympathomimetics, Vasodilator Agents

Computed Drug Properties

Molecular Weight (dalton): 363.461
LogP: 3.39018
Ring Count: 3
Hydrogen Bond Acceptor Count: 4
Hydrogen Bond Donor Count: 3
Total Polar Surface Area: 81.07

This panel provides information on interacting drugs and their ADRs along with references

Interacting drug Toxicity Interaction Type Mechanism Reference

This panel provides drug-protein interaction and their ADRs along with references

Toxicity Interacting Protein Mechanism Reference

This panel provides drug-food interactions and their ADRs along with references

Food Toxicity Reference

This panel provides information on metabolites and their ADRs along with references

Metabolite Toxicity Place of Metabolism Mechanism Reference

This panel provides information on drug category

Toxicity Source
Abdominal Discomfort MetaADEDB
Accelerated Hypertension MetaADEDB
Accident MetaADEDB
Aching Muscles MetaADEDB
Acute Myeloblastic Leukemia MetaADEDB
Allergic Dermatitis MetaADEDB
Alopecia MetaADEDB
Asthenia MetaADEDB
Benign Prostatic Hyperplasia MetaADEDB
Blood In Urine MetaADEDB
Blurred Vision MetaADEDB
Bronchial Infection MetaADEDB
Bronchitis MetaADEDB
Chromaturia MetaADEDB
Condition Aggravated MetaADEDB
Cough MetaADEDB
Cramp MetaADEDB
Csf Test Abnormal MetaADEDB
Dermographism MetaADEDB
Difficulty In Walking MetaADEDB
Dizziness MetaADEDB
Drug Effect Decreased MetaADEDB
Drug Ineffective MetaADEDB
Drug Withdrawal Headache MetaADEDB
Dry Skin MetaADEDB
Dyspepsia MetaADEDB
Eruption MetaADEDB
Eye Inflammation MetaADEDB
Facial Neuralgia MetaADEDB
Fatigue MetaADEDB
Flu MetaADEDB
Formication MetaADEDB
Hepatic Enzyme MetaADEDB
Herpes Zoster MetaADEDB
Histoplasmosis MetaADEDB
Hypoaesthesia MetaADEDB
Incision Site Abscess MetaADEDB
Infection Upper Respiratory MetaADEDB
Injection Site Burning MetaADEDB
Injection Site Dermatitis MetaADEDB
Injection Site Erythema MetaADEDB
Injection Site Inflammation MetaADEDB
Injection Site Irritation MetaADEDB
Injection Site Mass MetaADEDB
Injection Site Nodule MetaADEDB
Injection Site Pruritus MetaADEDB
Injection Site Stinging MetaADEDB
Injection Site Urticaria MetaADEDB
Injection Site Warmth MetaADEDB
Intervertebral Disc Degeneration MetaADEDB
Irregular Menstrual Cycle MetaADEDB
Itch MetaADEDB
Leg Amputation MetaADEDB
Localised Osteoarthritis MetaADEDB
Lymphoma MetaADEDB
Mouth Pain MetaADEDB
Multiple Sclerosis MetaADEDB
Myoglobin Blood Increased MetaADEDB
Nasal Sinus Congestion MetaADEDB
Nasopharyngitis MetaADEDB
Nausea MetaADEDB
Nerve Root Compression MetaADEDB
Neumonia MetaADEDB
Pain Exacerbated MetaADEDB
Pharyngeal Inflammation MetaADEDB
Pharyngolaryngeal Pain MetaADEDB
Polyneuropathy MetaADEDB
Psoriasis MetaADEDB
Pulmonary Congestion MetaADEDB
Rash Generalised MetaADEDB
Sinusitis MetaADEDB
Small Intestinal Stenosis MetaADEDB
Tarsal Tunnel Syndrome MetaADEDB
Trigger Finger MetaADEDB
Underdose MetaADEDB
Uterine Bleeding MetaADEDB
Uterine Polyp MetaADEDB
Vaginal Mycosis MetaADEDB

InAADR: Drug-Protein-ADRs database